Who
Freddy A. Jimenez
SVP & General Counsel
Company insider
Files Form 4 as: SVP & General Counsel, Celldex Therapeutics.
In numbers
- Trades disclosed
- 20
- Buys
- 1
- Sells
- 3
- Bought
- $20K
- Sold
- $409K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Jun 2021
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 4 Dec 2025filed 8 Dec 2025 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $121K4,166 at $29.10 | filing |
| 13 Aug 2025filed 15 Aug 2025 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $8,167341 at $23.95 | filing |
| 13 Aug 2025filed 15 Aug 2025 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $11K430 at $25.42 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —9,540 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $99K9,540 at $10.38 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —8,006 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $83K8,006 at $10.38 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $269K8,006 at $33.60 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,166 at $0.00 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $38K4,166 at $9.02 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $56K20,000 at $2.78 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —74,000 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —73,000 at $0.00 | filing |
| 11 Aug 2021filed 13 Aug 2021 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $20K430 at $46.28 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —73,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.